International Journal of Nanomedicine (Apr 2013)

Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid

  • Wang W,
  • Luo M,
  • Fu Y,
  • Wang S,
  • Efferth T,
  • Zu Y

Journal volume & issue
Vol. 2013, no. default
pp. 1377 – 1383

Abstract

Read online

Wei Wang,1–3 Meng Luo,1–3 Yujie Fu,1–3 Song Wang,1–3 Thomas Efferth,4 Yuangang Zu1–3 1Key Laboratory of Forest Plant Ecology, 2Engineering Research Center of Forest Bio-Preparation, 3State Engineering Laboratory of Bio-Resource Eco-Utilization, Northeast Forestry University, Harbin, China; 4Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Mainz, Germany Abstract: Glycyrrhizic acid (GA), the main component of radix glycyrrhizae, has a variety of pharmacological activities. In the present study, suspensions of GA nanoparticles with the average particle size about 200nm were prepared by a supercritical antisolvent (SAS) process. Comparative studies were undertaken using lipopolysaccardide(LPS)-stimulated mouse macrophages RAW 264.7 as in vitro inflammatory model. Several important inflammation mediators such as NO, PGE2, TNF-α and IL-6 were examined. These markers were highly stimulated by LPS and were inhibited both by nano-GA and unprocessed GA in a dose-dependent manner, especially PGE2 and TNF-α. However nano-GA and unprocessed GA inhibited NO only at a high concentration. In general, we found that GA nanoparticle suspensions exhibited much better anti-inflammatory activities compared to unprocessed GA. Keywords: glycyrrhizic acid, nanoparticle, mouse macrophages RAW 264.7, inflammatory cytokines